Form 8-K - Current report:
SEC Accession No. 0001789769-25-000024
Filing Date
2025-03-31
Accepted
2025-03-28 17:38:03
Documents
57
Period of Report
2025-03-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K til-20250328.htm   iXBRL 8-K 40619
2 EX-1.1 exh11instil-2025atmxopen.htm EX-1.1 155576
3 EX-5.1 instilbio-2025atmx51opin.htm EX-5.1 6156
7 exh11instil-2025atmxopen001.jpg GRAPHIC 183343
8 exh11instil-2025atmxopen002.jpg GRAPHIC 224469
9 exh11instil-2025atmxopen003.jpg GRAPHIC 293968
10 exh11instil-2025atmxopen004.jpg GRAPHIC 316283
11 exh11instil-2025atmxopen005.jpg GRAPHIC 307496
12 exh11instil-2025atmxopen006.jpg GRAPHIC 298755
13 exh11instil-2025atmxopen007.jpg GRAPHIC 294336
14 exh11instil-2025atmxopen008.jpg GRAPHIC 308633
15 exh11instil-2025atmxopen009.jpg GRAPHIC 301749
16 exh11instil-2025atmxopen010.jpg GRAPHIC 267081
17 exh11instil-2025atmxopen011.jpg GRAPHIC 343729
18 exh11instil-2025atmxopen012.jpg GRAPHIC 317068
19 exh11instil-2025atmxopen013.jpg GRAPHIC 322386
20 exh11instil-2025atmxopen014.jpg GRAPHIC 316312
21 exh11instil-2025atmxopen015.jpg GRAPHIC 325485
22 exh11instil-2025atmxopen016.jpg GRAPHIC 328326
23 exh11instil-2025atmxopen017.jpg GRAPHIC 258191
24 exh11instil-2025atmxopen018.jpg GRAPHIC 274309
25 exh11instil-2025atmxopen019.jpg GRAPHIC 278436
26 exh11instil-2025atmxopen020.jpg GRAPHIC 289717
27 exh11instil-2025atmxopen021.jpg GRAPHIC 321580
28 exh11instil-2025atmxopen022.jpg GRAPHIC 318539
29 exh11instil-2025atmxopen023.jpg GRAPHIC 312166
30 exh11instil-2025atmxopen024.jpg GRAPHIC 317206
31 exh11instil-2025atmxopen025.jpg GRAPHIC 261502
32 exh11instil-2025atmxopen026.jpg GRAPHIC 320469
33 exh11instil-2025atmxopen027.jpg GRAPHIC 298830
34 exh11instil-2025atmxopen028.jpg GRAPHIC 297133
35 exh11instil-2025atmxopen029.jpg GRAPHIC 289615
36 exh11instil-2025atmxopen030.jpg GRAPHIC 304843
37 exh11instil-2025atmxopen031.jpg GRAPHIC 334875
38 exh11instil-2025atmxopen032.jpg GRAPHIC 350306
39 exh11instil-2025atmxopen033.jpg GRAPHIC 297301
40 exh11instil-2025atmxopen034.jpg GRAPHIC 266531
41 exh11instil-2025atmxopen035.jpg GRAPHIC 258371
42 exh11instil-2025atmxopen036.jpg GRAPHIC 195677
43 exh11instil-2025atmxopen037.jpg GRAPHIC 304133
44 exh11instil-2025atmxopen038.jpg GRAPHIC 67861
45 exh11instil-2025atmxopen039.jpg GRAPHIC 100922
46 exh11instil-2025atmxopen040.jpg GRAPHIC 33786
47 instilbio-2025atmx51opin001.jpg GRAPHIC 252838
48 instilbio-2025atmx51opin002.jpg GRAPHIC 123130
  Complete submission text file 0001789769-25-000024.txt   16199635

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT til-20250328.xsd EX-101.SCH 1773
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT til-20250328_lab.xml EX-101.LAB 22530
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT til-20250328_pre.xml EX-101.PRE 13038
59 EXTRACTED XBRL INSTANCE DOCUMENT til-20250328_htm.xml XML 2804
Mailing Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219
Business Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219 (972) 499-3350
Instil Bio, Inc. (Filer) CIK: 0001789769 (see all company filings)

EIN.: 832072195 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40215 | Film No.: 25788067
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)